Metabolic

GLP-1 receptor agonists, dual and triple incretin agonists, and metabolic tool compounds studied in preclinical models of insulin secretion, energy homeostasis, and adipose tissue regulation. Includes Semaglutide, Tirzepatide, Retatrutide, and AOD-9604.

⚠ All products are for research use only. Not for human consumption.